NCT06780462View on ClinicalTrials.gov

Randomized Controlled Multicenter Study Comparing Steroid Therapy Plus Anticoagulants to Steroid Therapy Alone in Deep Venous Thrombosis of Behçet's Syndrome

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

134

Participants

Timeline

Start Date

January 15, 2025

Primary Completion Date

July 15, 2027

Study Completion Date

January 15, 2028

Conditions
Behcet Syndrome
Interventions
DRUG

Corticosteroids + Rivaroxaban

Corticosteroids according to the schedule of reduction of prednisone (or equivalent prednisone dose only if prednisone is out of stock in the market) and Rivaroxaban

DRUG

Corticosteroids alone

Corticosteroids according to the schedule of reduction of prednisone (or equivalent prednisone dose only if prednisone is out of stock in the market)

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER